General Updates

CSD/BSE&NSE/BRSR 2025-26 Date: July 30, 2026 To To Listing Department Listing Department BSE Limited National Stock Exchange of India Limited 25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 530239 Scrip Symbol: SUVEN Dear Sir/Madam, Sub: Business Responsibility and Sustainability Report for FY 2025-26 Pursuant to Regulation 34 of SEBI (LODR) Regulations, 2015, please find enclosed the Business Responsibility and Sustainability Report (BRSR) for the FY 2025-26 which forms part of the Annual Report FY 2025-26. This is for your information and record. Thanking you, For Suven Life Sciences Limited K. Sangeetha Laxmi Company Secretary Encl.: as above Suven Life Sciences Limited Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor Road No.5 I Avenue 7 Banjara Hills I Hyderabad – 500 034 I Telangana I India I CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 3311/ 3315 Fax: 91 40 2354 1152 Email: info@suven.com website: www.suven.com SUVEN LIFE SCIENCES LIMITED BUSINESS RESPONSIBILITY AND SUSTAINABILITY REPORT [Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015] The present report has been formulated in accordance with the SEBI Guidelines for Business Responsibility and Sustainability Reporting (BRSR). Its principal aim is to enhance transparency by showcasing how businesses generate value through active contributions to a sustainable economy. The report serves to emphasise our steadfast dedication to fostering sustainable development and creating enduring value for our stakeholders. SECTION A: GENERAL DISCLOSURES 1) DETAILS OF THE ENTITY Serial Particulars Response 1. Corporate identity Number (CIN) of the Listed Entity L24110TG1989PLC009713 2. Name of the Listed Entity Suven Life Sciences Limited 3. Year of incorporation 1989 4. Registered office address 8-2-334, SDE Serene Chambers, 6th Floor, Road No.5, Avenue 7, Banjara Hills, Hyderabad – 500 034, Telangana, India. 5. Corporate address 8-2-334, SDE Serene Chambers, 6th Floor, Road No.5, Avenue 7, Banjara Hills, Hyderabad – 500 034, Telangana, India. 6. E-mail investorservices@suven.com 7. Telephone +91 040 2354 1142/ 1152 8. Website www.suven.com 9. Financial year for which reporting is being done FY 2025-26 10. Name of the Stock Exchange(s) where shares are listed BSE Limited and National Stock Exchange of India Limited 11. Paid-up Capital C 26,37,20,583 12. Name and contact details (telephone, email address) of Ms. K Sangeetha Laxmi, Company Secretary the person who may be contacted in case of any queries Telephone: 040 2354 1142/1152 on the BRSR report Email: investorservices@suven.com 13. Reporting boundary - Are the disclosures under this Standalone basis report made on a standalone basis (i.e., only for the entity) or on a consolidated basis (i.e. for the entity and all the entities which form a part of its consolidated financial statements, taken together). 14. Name of assessment or assurance provider J Sundharesan & Associates 15. Type of assessment or assurance obtained Limited Assurance 2) PRODUCTS/SERVICES 16. Details of business activities (accounting for 90% of the turnover): S. No. Description of Main Activity Description of Business Activity % of Turnover of the entity 1. Professional, scientific and technical Scientific research and development 100 CORPORATE STATUTORY FINANCIAL ANNUAL REPORT 2025-26 OVERVIEW REPORTS STATEMENTS 17. Products/Services sold by the entity (accounting for 90% of the entity’s Turnover): Product/Service NIC Code % of total Turnover contributed 1. Scientific Research & Technical Services 74909 100 3. OPERATIONS 18. Number of locations where plants and/or operations/offices of the entity are situated: Location Number of plants Number of offices Total National 3 1 4 International 0 0 0 19. Markets served by the entity: a) Number of locations Locations Number National (No. of States) 2 International (No. of Countries) 4 b) Contribution of exports: What is the contribution of exports as a percentage of the total turnover of the entity? 70 c) Type of Customers A brief on types of customers Suven Life Sciences is primarily engaged in providing services to • Pharmaceutical Companies • Life Sciences Companies. 4. EMPLOYEES 20. Details at the end of the year of financial year: a) Employees and workers (including differently abled): S. Male Female Particulars Total (A) No No. (B) % (B / A) No. (C) % (C / A) Employees 1. Permanent (D) 142 102 72 40 28 2. Other than Permanent (E) 0 0 0 0 0 3. Total employees (D + E) 142 102 72 40 28 Workers 1. Permanent (F) 0 0 0 0 0 2. Other than Permanent (G) 39 37 95 2 5 3. Total workers (F + G) 39 37 95 2 5 SUVEN LIFE SCIENCES LIMITED b) Differently abled Employees and workers: S. Male Female Particulars Total (A) No No. (B) % (B / A) No. (C) % (C / A) Differently Abled Employees 1. Permanent (D) 2. Other than Permanent (E) NIL 3. Total differently abled employees (D + E) Differently Abled Workers 1. Permanent (F) 2. Other than Permanent (G) NIL 3. Total differently abled workers (F + G) • Permanent Employees: Includes all full-time and part-time employees on the payroll. • Other than Permanent Employees: Comprises contractual associates, interns, trainees. • Permanent Workers: None. • Other than Permanent Workers: Includes casual staff, administration, security, and housekeeping personnel. 21. Participation/Inclusion/Representation of women: No. and percentage of Females Category Total (A) No. (B) % (B / A) Board of Directors 6 2 33.33 Key Management Personnel* 2 1 50 *Key Management Personnel includes Company Secretary and Chief Financial Officer. 22. Turnover rate for permanent employees and workers: FY 2024-25 FY 2023-24 FY 2025-26 (Turnover rate in (Turnover rate in the year (Turnover rate in current FY) previous FY) prior to the previous FY) Male Female Total Male Female Total Male Female Total Permanent Employees 8.8 10.3 9.28 14 5 19 17 7 24 Permanent Workers NIL NIL NIL NIL NIL NIL NIL NIL NIL 5. HOLDING, SUBSIDIARY AND ASSOCIATE COMPANIES (INCLUDING JOINT VENTURES) 23. Names of holding / subsidiary / associate companies / joint ventures: Name of the holding / Indicate whether Does the entity indicated at S. subsidiary / associate holding/ Subsidiary/ % of shares held by column A, participate in the No. companies / joint Associate/ Joint listed entity Business Responsibility initiatives ventures (A) Venture of the listed entity? (Yes/No) 1. Suven Neurosciences Inc. Subsidiary 100 No CORPORATE STATUTORY FINANCIAL ANNUAL REPORT 2025-26 OVERVIEW REPORTS STATEMENTS 6. CORPORATE SOCIAL RESPONSIBILITY (CSR) DETAILS Requirement Response 1. Whether CSR is applicable as per section 135 of Companies Act, 2013: (Yes/No) No 2. Turnover (in C ) 7,11,46,912 3. Net worth (in C ) 15,03,36,72,067 7. TRANSPARENCY AND DISCLOSURES COMPLIANCES 25. Complaints/Grievances on any of the principles (Principles 1 to 9) under the National Guidelines on Responsible Business Conduct: Grievance FY 2025-26 (Current Financial Year) FY 2024-25 (Previous Financial Year) Redressal Number of Number of Stakeholder Number of Number of Mechanism in Place complaints complaints group from complaints complaints (Yes/No) (If yes, pending pending whom complaint filed Remarks filed Remarks then provide web- resolution resolution at is received during the during the link for grievance at close of close of the year year redress policy) the year year Communities Yes, NIL NIL None NIL NIL None www.suven.com/ pdf/BRSR_Policies_ Suven-Life.pdf Investors (other NA NIL NIL None NIL NIL None than shareholders) Shareholders Yes, NIL NIL None NIL NIL None www.suven.com/ pdf/BRSR_Policies_ Suven-Life.pdf Employees and Yes, NIL NIL None NIL NIL None workers www.suven.com/ pdf/BRSR_Policies_ Suven-Life.pdf Customers Yes NIL NIL None NIL NIL None www.suven.com/ pdf/BRSR_Policies_ Suven-Life.pdf Value Chain Yes, NIL NIL None NIL NIL None Par [Showing first 8,000 characters — download PDF for full document]